MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...
Current local time in Moscow Daylight Time (Moscow Daylight Time time zone). Get information about the Moscow Daylight Time time zone. Local time and date, DST adjusted (where ever daylight saving ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback